Hudson Bay Capital Management’s Medicines Co MDCO Stock Holding History

Hudson Bay Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-191,624	Closed	-$16.3M	–	674
2019 Q4	$16.3M	Buy	+191,624	New	+$12.8M	0.36%	46
2019 Q3	–	Sell	-70,000	Closed	-$2.55M	–	516
2019 Q2	$2.55M	Sell	70,000 -55,000	-44%	-$1.8M	0.06%	247
2019 Q1	$3.49M	Buy	125,000 +75,700	+154%	+$1.78M	0.05%	354
2018 Q4	$944K	Buy	49,300 +9,300	+23%	+$216K	0.01%	644
2018 Q3	$1.2M	Hold	40,000	–	–	0.01%	552
2018 Q2	$1.47M	Buy	+40,000	New	+$1.3M	0.02%	578

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Hudson Bay Capital Management's MDCO Position: Q1 2020 in Review

Hudson Bay Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 191,624 shares — an estimated $16.3M sold.

Hudson Bay Capital Management first reported a position in MDCO in Q2 2018 and held it in 6 quarters. The position peaked at $16.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Hudson Bay Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 191,624 Medicines Co shares in Q1 2020, an estimated $16.3M.
Hudson Bay Capital Management first reported a position in Medicines Co in Q2 2018 and held it in 6 quarters.
Hudson Bay Capital Management's Medicines Co position peaked at $16.3M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Hudson Bay Capital Management's 13F filing for Q1 2020, filed 14 May 2020.